One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2018-99-118280
Copy DOI Journal: Blood |  Publication Date: Nov 29, 2018 |
 Citations: 1 |
Affiliation: Istituto di Ematologia di Bologna, Sapienza University of Rome, Ospedale Vito Fazzi, University of Ferrara, University of Turin, Fondazione Gimema Onlus, Ospedale "Santa Maria delle Croci" di Ravenna, Policlinico Umberto I, University of Bologna, University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Azienda Sanitaria Universitaria Integrata di Trieste, University of Modena and Reggio Emilia, University of Perugia, Ospedale Policlinico San Martino, Università Cattolica del Sacro Cuore, Fondazione IRCCS Istituto Nazionale dei Tumori, Spedali Civili di Brescia, Azienda Ospedaliera Pugliese Ciaccio, Azienda Ospedaliera Citta' della Salute e della Scienza di Torino, St. Eugenio Hospital, Ospedale Niguarda Ca' Granda, University of Eastern Piedmont Amadeo Avogadro, Humanitas University, Istituti di Ricovero e Cura a Carattere Scientifico, Vita-Salute San Raffaele UniversityOutcome of Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) Treated with Ibrutinib within a Named Patient Program (NPP) in Italy. a Real-Life Retrospective Study
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
